ArticleBone marrow transplantation2024

Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation.

Maria Chiara Finazzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.